Get startedLog in
    Picture of Amniotics AB (publ) logo

    AMNI — Amniotics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Amniotics Announces Positive Pre-Clinical Proof-Of-Concept Results For Pulmostem In End-Stage Lung Disease

    Picture of Amniotics AB (publ) logoAmniotics AB (publ)
    28/04/2022 15:03
    April 28 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * AMNIOTICS AB ANNOUNCES POSITIVE PRE-CLINICAL
PROOF-OF-CONCEPT
RESULTS FOR PULMOSTEM™ IN END-STAGE LUNG DISEASE
    * PULMOSTEMTM SIGNIFICANTLY REDUCES INCIDENCE OF PRIMARY
GRAFT
DYSFUNCTION (PGD) IN PRE-CLINICAL STUDY OF LUNG TRANSPLANTATION

Source text for Eikon:  ID:nMFN17yDl 
Further company coverage:  AMNI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Amniotics AB (publ)

    See all news